Biopure

11 Hurley St
Cambridge
MA
02141
United States
(617) 234-6500
Product(s): 
Develops, manufactures and markets hemoglobin-based oxygen therapeutic products
Ownership: 
Public
Exchange: 
NSDQ
symbol: 
BPUR
2004 Revenue: 
$3,750,000
2005 Revenue: 
$2,110,000
2006 Revenue: 
$1,715,000
2007 Revenue: 
$2,556,000
2008 Revenue: 
$3,128,000
Yahoo Quotes: 

Chairman: 
Zafiris G. Zafirelis
President: 
Zafiris G. Zafirelis
CEO: 
Zafiris G. Zafirelis
Management: 
David A. Butler, interim CFO
Jane Kober, SVP, general counsel, secretary
Geoffrey J. Filbey, VP-engineering
A. Gerson Greenburg, VP-medical Affairs
W. Richard Light, VP-technology development
Virginia T. Rentko, VP-preclinical development
Barry L. Scott, VP-business development
Biopure

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp